Cancer risks and perspectives: molecular mechanisms.

[1]  M. Socinski,et al.  Erlotinib in African Americans With Advanced Non–Small Cell Lung Cancer: A Prospective Randomized Study With Genetic and Pharmacokinetic Analyses , 2014, Clinical pharmacology and therapeutics.

[2]  Cord Langner,et al.  Cancer Management and Research Dovepress Prognostic Stratification of Colorectal Cancer Patients: Current Perspectives , 2022 .

[3]  O. Aruoma,et al.  Cancer: Global Health Perspectives , 2014 .

[4]  Lisa M Hess,et al.  Perspectives of quality care in cancer treatment: a review of the literature. , 2013, American health & drug benefits.

[5]  Yong-Xin Li,et al.  Triterpenoids of Marine Origin as Anti-Cancer Agents , 2013, Molecules.

[6]  A. Rong,et al.  Evaluation of Progression-Free Survival as a Surrogate Endpoint for Survival in Chemotherapy and Targeted Agent Metastatic Colorectal Cancer Trials , 2013, Clinical Cancer Research.

[7]  Olivier Saint-Jean,et al.  Physicians' perceptions of cancer care for elderly patients: a qualitative sociological study based on a pilot geriatric oncology program. , 2010, Critical reviews in oncology/hematology.

[8]  D. Sumi,et al.  Signal transduction pathways and transcription factors triggered by arsenic trioxide in leukemia cells. , 2010, Toxicology and applied pharmacology.

[9]  O. Aruoma,et al.  Inflammation, cellular and redox signalling mechanisms in cancer and degenerative diseases. , 2005, Mutation research.

[10]  L. Balducci.  New paradigms for treating elderly patients with cancer: the comprehensive geriatric assessment and guidelines for supportive care. , 2003, The journal of supportive oncology.

[11]  R. Berlinck,et al.  Marine organisms as a source of new anticancer agents. , 2001, The Lancet. Oncology.

[12]  O. Aruoma,et al.  The antioxidant action of N-acetylcysteine: its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acid. , 1989, Free radical biology & medicine.